Analyzing Oruka Therapeutics (NASDAQ:ORKA) & ImmuCell (NASDAQ:ICCC)
ImmuCell (NASDAQ:ICCC – Get Free Report) and Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings. Insider & Institutional Ownership 13.5% of ImmuCell shares […]
More Stories
Veeco Instruments (NASDAQ:VECO) Downgraded by StockNews.com
StockNews.com cut shares of Veeco Instruments (NASDAQ:VECO – Free Report) from a hold rating to a sell rating in a...
XOS (NASDAQ:XOS) Raised to “Strong-Buy” at Northland Capmk
Northland Capmk upgraded shares of XOS (NASDAQ:XOS – Free Report) to a strong-buy rating in a report issued on Wednesday,...
Verona Pharma (NASDAQ:VRNA) Now Covered by Wells Fargo & Company
Equities research analysts at Wells Fargo & Company began coverage on shares of Verona Pharma (NASDAQ:VRNA – Get Free Report)...
Analysts Set BP p.l.c. (LON:BP) Target Price at GBX 636.67
Shares of BP p.l.c. (LON:BP – Get Free Report) have received a consensus recommendation of “Hold” from the eight brokerages...
Contrasting ExlService (NASDAQ:EXLS) & MOGU (NYSE:MOGU)
MOGU (NYSE:MOGU – Get Free Report) and ExlService (NASDAQ:EXLS – Get Free Report) are both retail/wholesale companies, but which is...
Comparing Energy Fuels (NYSE:UUUU) & Intrepid Potash (NYSE:IPI)
Intrepid Potash (NYSE:IPI – Get Free Report) and Energy Fuels (NYSE:UUUU – Get Free Report) are both small-cap basic materials...